Lenz et al. further showed that DLBCL overexpressing miR-17-92 also expresses MYC and its target genes at significantly higher levels than DLBCL that does not overexpress miR-17-92 [150]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.